CBV

5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE)

Created:	2006-10-19
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where CBV is found as a standalone ligand2 entries where CBV is covalently linked to polymer or other heterogen groups 47 entries where CBV is found in a polymer sequence

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	4
Bond Count	36
Aromatic Bond Count	0

2D diagram of CBV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE)
Systematic Name (OpenEye OEToolkits)	[(2R,3S,4R,5R)-5-(4-amino-5-bromo-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate
Formula	C₉ H₁₃ Br N₃ O₈ P
Molecular Weight	402.093
Type	RNA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	BrC=1C(=NC(=O)N(C=1)C2OC(C(O)C2O)COP(=O)(O)O)N
SMILES	CACTVS	3.341	NC1=NC(=O)N(C=C1Br)[CH]2O[CH](CO[P](O)(O)=O)[CH](O)[CH]2O
SMILES	OpenEye OEToolkits	1.5.0	C1=C(C(=NC(=O)N1C2C(C(C(O2)COP(=O)(O)O)O)O)N)Br
Canonical SMILES	CACTVS	3.341	NC1=NC(=O)N(C=C1Br)[C@@H]2O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]2O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C1=C(C(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)Br
InChI	InChI	1.03	InChI=1S/C9H13BrN3O8P/c10-3-1-13(9(16)12-7(3)11)8-6(15)5(14)4(21-8)2-20-22(17,18)19/h1,4-6,8,14-15H,2H2,(H2,11,12,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1
InChIKey	InChI	1.03	KOHPTSGPCYTYFB-UAKXSSHOSA-N

Related Resource References

Resource Name	Reference
PubChem	172916

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.